Legal Opinion
Federal Trade Commission v. Lundbeck, Inc.
Court of Appeals for the Eighth Circuit
Decided August 19, 2011No. 10-3458, 10-3459PublishedCited by 11 opinions
1Opinion of the Court
BENTON, Circuit Judge.
The Federal Trade Commission and Minnesota (collectively the FTC) sued Lundbeck, Inc., alleging its acquisition of the drug NeoProfen violated the Federal Trade Commission Act, the Sherman Act, the Clayton Act, the Minnesota Antitrust Law of 1971, and unjustly enriched Lundbeck. After a bench trial, the district court2 ruled for Lundbeck based on the FTC’s failure to identify a relevant market.
Patent ductus arteriosus (PDA) is a life-threatening heart condition that primarily affects low-birth-weight, usually premature, babies. There are two primary treatments:…
2Cases cited23 opinions
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- Pullman-Standard v. SwintSupreme Court of the United States · 1982
- Bose Corp. v. Consumers Union of United States, Inc.Supreme Court of the United States · 1984
- Brown Shoe Co. v. United StatesSupreme Court of the United States · 1962
- United States v. Microsoft Corp.Court of Appeals for the D.C. Circuit · 2001
18 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- United Food & Commercial Workers Local 1776 & Participating Emp'rs Health & Welfare Fund v. Teikoku Pharma United StatesDistrict Court, N.D. California · 2017
- United States v. James WallerCourt of Appeals for the Eighth Circuit · 2012
- Federal Trade Commission v. Sanford HealthCourt of Appeals for the Eighth Circuit · 2019
- Indigo LR LLC v. Advanced Insurance Brokerage of America Inc.Court of Appeals for the Eighth Circuit · 2013
- Federal Trade Commission v. Penn State Hershey Medical CenterDistrict Court, M.D. Pennsylvania · 2016
6 more not listed; retrieve them via the Exa API.